APLS
Apellis Pharmaceuticals
APLS
APLS
Delisted
APLS was delisted on the 13th of May, 2026.
313 hedge funds and large institutions have $5.46B invested in Apellis Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 124 funds opening new positions, 86 increasing their positions, 70 reducing their positions, and 74 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
23% more repeat investments, than reductions
Existing positions increased: 86 | Existing positions reduced: 70
13% more funds holding
Funds holding: 276 → 313 (+37)
7.89% more ownership
Funds ownership: 99.87% → 107.76% (+7.9%)
Holders
313
Holding in Top 10
6
Calls
$52.1M
Puts
$36.5M
Top Buyers
| 1 | +$157M | |
| 2 | +$113M | |
| 3 | +$77.3M | |
| 4 |
HI
HBK Investments
Dallas,
Texas
|
+$76.5M |
| 5 |
State Street
Boston,
Massachusetts
|
+$48.1M |
Top Sellers
| 1 | -$269M | |
| 2 | -$93.1M | |
| 3 | -$85.8M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$69.3M |
| 5 |
SL
Siren LLC
Greenwich,
Connecticut
|
-$64.8M |
